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AbstrACt
Objective To describe the end-of-life care preferences 
of individuals, and to examine the influence of age and 
gender on these preferences.
Design, setting and participants A retrospective cohort 
study was conducted. Participants included all adults 
(≥21 years old) (n=3380) who had completed a statement 
of their preferences as part of a national Advance Care 
Planning (ACP) programme in Singapore. Data were 
extracted from the national and Tan Tock Seng Hospital 
ACP database.
Main measures End-of-life care preferences were 
obtained from the ACP document and differentiated by 
health status (healthy, chronically ill or diagnosed with 
advanced illnesses). To analyse the data, descriptive 
statistics and logistic regression analysis were used.
results Across healthy and chronically ill patients, the 
majority did not opt for cardiopulmonary resuscitation 
(CPR) or other life-sustaining measures. Among individuals 
with advanced illnesses, 94% preferred not to attempt 
CPR but 69% still preferred to receive some form of active 
medical treatment. Approximately 40% chose to be cared 
for, and to die at home. Age and sex significantly predict 
preferences in those with advanced illnesses. Older age 
(>=75 years) showed higher odds for home as preferred 
place of care (OR 1.52; 95% CI 1.23 to 1.89) and place of 
death (OR 1.29; 95% CI 1.03 to 1.61) and lower odds for 
CPR (OR 0.31; 95% CI 0.18 to 0.54) and full treatment (OR 
0.32; 95% CI 0.17 to 0.62). Being female was associated 
with lower odds for home as preferred place of care (OR 
0.69; 95% CI 0.57 to 0.84) and place of death (OR 0.70; 
95% CI 0.57 to 0.85) and higher odds for full treatment (OR 
2.35; 95% CI 1.18 to 4.68).
Conclusion The majority preferred to not proceed with 
life-sustaining treatments, but there was still a strong 
preference to receive some form of limited treatment. 
Better understanding of end-of-life care preferences 
through ACP can better guide end-of-life care programme 
planning, and resource allocation decisions.
IntrODuCtIOn 
Most societies that are experiencing a rapidly 
ageing population would encounter chal-
lenges in providing high quality end-of-life 
care to its population. In many jurisdictions, 
through a process of Advance Care Plan-
ning (ACP), an individual could designate a 
healthcare decision-maker, and specify deci-
sions regarding life-sustaining treatments 
in the event of decisional incapacitation. 
Research has found ACP to empower patients 
with a greater peace of mind,1 improve the 
level of agreement with regards to end-of-life 
care between patient and surrogate, reduce 
decisional conflict2 and improve their satis-
faction with care.3 The likelihood of dying at 
their preferred place was also higher among 
individuals who had completed an ACP4 ; the 
transition between acute and terminal care is 
often smoother.5 ACP was also associated with 
avoiding or reducing unnecessary life-sus-
taining treatments,1 4 increasing the inci-
dence of out-of-hospital and out-of-intensive 
care, and increasing the probability of dying 
at home.6–9 
With this perspective, the Singapore 
government launched a comprehensive 
national ACP programme, ‘Living Matters’, 
strengths and limitations of this study
 ► Examined real-life end-of-life care  preferences of 
individuals across different health states.
 ► Comprehensive coverage of a large sample of pa-
tients who received care from seven acute care hos-
pitals, and twelve different social care providers in 
Singapore.
 ► Examined the association of end-of-life care prefer-
ences with age and sex but was unable to examine 
the correlation with other covariates due to data 
limitation.
 ► Individuals who voluntarily completed their advance 
care plans could be less death avoidant.
 ► Prospective study will allow for gathering of more 
variables that influence end-of-life care preferences 
which this study lacks.
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in 2011. ‘Living Matters’ is based on the Respecting 
Choices programme at the Gundersen Health System 
in Wisconsin, USA. Primarily, the programme aims to 
systematise the elicitation and documentation of medical 
and care preferences,10 with a longer-term goal of normal-
ising death and dying conversations in the community.11 12 
Listed among populations that are ageing most rapidly in 
the world, this is a timely effort, as the need to cater for 
healthcare, including end-of-life care of the population, 
is expected to intensify alongside the doubling of the 
elderly population.13
Surveys have been conducted locally to profile the 
end-of-life care preferences across different patients 
and community-based samples.14–17 However, surveys 
often require individuals to respond to a single question 
about their preferred place of death, based on a hypo-
thetical end-of-life scenario18 without having to trade off 
against other priorities or account for other than one’s 
personal concerns. Therefore, choices elicited through a 
survey could reflect what is preferred under more ‘ideal’ 
circumstances. Since an illness impacts the individual 
biologically as well as socially,19 the survey process may 
not mirror real-life decision-making processes well.20
Therefore, in this article, we review the demographics 
and end-of-life care preferences, as documented in an 
Advance Care Plan. Given that end-of-life care prefer-
ences could differ across different health states and over 
one’s life cycle,21 preferences are profiled according to 
the health status of those expressing them. Additionally, 
we also examined the effect of age and gender on stated 
preferences.
MethODOlOgy
ACP programme
The ‘Living Matters’ programme comprised three inte-
grated components1: provision of patient educational 
materials2; trained and certified ACP facilitators who assist 
individuals with ACP3; development of an IT system to 
enable easily storage, and retrieval of ACP forms.22 23 The 
programme has adopted a staged approach that considers 
a person’s state of health and allows ACP to be conducted 
in phases across one’s lifetime. The conversations can 
then be individualised based on one’s health status, which 
is broadly categorised as healthy, diagnosed with complex 
chronic illnesses or diagnosed with advanced illnesses.
Currently, referral to ACP and the staging of one’s 
health status is largely based on clinical judgement. Indi-
vidual clinicians also assess the individual patient’s readi-
ness to discuss end-of-life care issues. In practice, a social 
care or healthcare professional may facilitate a conver-
sation between the patient and his/her family members 
to explore his/her values, beliefs and how this impacts 
preferences towards medical care at the end of life. ACP 
is not legally binding in Singapore and, therefore, there 
is no need to engage a lawyer for its discussion or docu-
mentation.24 All participating patients are encouraged 
to identify a substitute decision-maker (SDM) who can 
make healthcare decisions on their behalf in the event of 
incapacitation.
Different questions and standardised forms apply to 
each of the three health states (healthy, chronically ill, 
with advanced illness) (figure 1). Individuals identify a 
substitute decision-maker and also establish the goals of 
care relevant to their disease stage. They are intended to 
update their decisions as they transit health states. For 
instance, questions regarding disease-related complica-
tions are not applicable to a healthy individual whereas, 
for an individual with a poor prognosis, questions related 
to disease-related complications may no longer be appli-
cable. Rather, they may be concerned about care during 
the terminal phase.
End-of-life care preferences are documented in an IT 
system after obtaining the patient’s concurrence that they 
accurately reflect their decisions. These recorded pref-
erences are accessible to different providers across the 
acute care continuum.
study design and population
This is a retrospective cohort study that included all indi-
viduals aged 21 years and above, who have completed 
their ACP between January 2011 and December 2015 
across all participating acute care hospitals, specialist care 
centres and social care providers in Singapore.
Patient and public involvement
Patients were not involved in the design of the study 
although end-of-life care preferences documented as part 
of routine clinical care were aggregated and reported in 
this study. As only anonymised data were analysed, data 
were not disseminated to the patients.
ethics and consent
Ethics approval was obtained. As this is a retrospective 
database study, written informed consent was waived .
elicited preferences by health status
There were three different forms, general, disease 
specific, and the preferred plan of care form, to cater to 
individuals at different health stages (healthy, chronically 
ill, advanced illness).
Figure 1 End-of-life care decisions by health status.
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For healthy adults, they were asked about their prefer-
ences related to the goals of care when the probability 
of recovery or survival is low. The choices provided were: 
‘make comfort the goal of my care and do not prolong 
my life in this condition’ or ‘continue to provide all neces-
sary life-sustaining treatment until outcomes happen to 
me which I find unacceptable’.
For individuals with chronic conditions, the wishes 
documented in an ACP form specifies preferences about 
cardiopulmonary resuscitation (CPR) during cardiac 
arrest and decisions about treatment options if they were 
to develop serious complications with (1) a low like-
lihood of survival, (2) a high likelihood of survival but 
might become immobile and unable to communicate or 
(3) a high likelihood of survival but might suffer from 
permanent cognitive impairment. The choice catego-
ries include ‘all treatment I need to live as long as I can’, 
‘stop all efforts to keep me alive, allow natural death to 
happen’ and ‘unsure’.
For individuals with advanced illnesses, they were 
asked about their CPR preferences, decisions related 
to medical intervention (comfort, limited additional 
interventions, full treatment), place of care and place 
of death. Under the current programme, full treat-
ment considers intubation, mechanical ventilation and 
cardioversion. Medical management may also include 
transfer to intensive care if indicated. Limited addi-
tional interventions include comfort measures and may 
also include oral or intravenous medications. While 
non-invasive ventilation support is acceptable, endo-
tracheal intubation or long-term life support measures, 
including admission to intensive care units, are not. 
Comfort measures include reasonable measures made 
to offer food and fluids. Medications, oxygen and other 
measures may be used as needed for comfort, but it 
does not include intubation.
For place of medical treatment or care, individuals 
could opt for the home, hospice, nursing home, hospital, 
a trial of treatment in their homes before considering 
transfer to a hospital or a hospice and a trial of treat-
ment in the hospice or nursing home before transfer to a 
hospital. The documentation also allowed the individual 
to indicate ‘no preferences’ and ‘others’. For place of 
death, individuals are asked where they would wish to be 
if they were left with 2–3 days of life. They could opt for 
either the home, hospital, hospice or nursing home, and 
two or more alternatives such as home or hospital, and 
home or nursing home or hospital.
Measures and data extraction
We extracted data on available personal characteristics of 
patients (age/gender) and preferences from the national 
ACP IT system and the Tan Tock Seng Hospital ACP data-
base. Data fields related to the nomination of a substitute 
decision maker(s), preference about the administration 
of CPR in the event of a cardiac arrest and end-of-life 
care preferences were extracted. In addition, for patients 
diagnosed with advanced illnesses, we extracted their 
preferences for place of care and death as well.
To ascertain whether the individuals were deceased, the 
data were linked to death-related data from the National 
Registry of Birth and Deaths. Every Singaporean resi-
dent is issued with a National Registration Identity Card 
(NRIC) number. For this study, a project unique identi-
fying number (PUIN) was generated for each NRIC by a 
third-party vendor, who was not involved in the analysis of 
the data. The PUIN was then used to link data belonging 
to each individual person across the data sets.
Data analysis
Descriptive statistics were used to profile the sample 
and to summarise the basic characteristics of the data. 
Frequency distribution tables were created to profile the 
characteristics of the study samples and to describe the 
documented end-of-life care preferences. A χ2 test was 
used to determine whether a statistically significant rela-
tionship exists between two or more categorical variables.
We examined the independent effects of age and 
gender on four different end-of-life care statement of 
preference. We dichotomised the preferences for: (1) 
CPR (‘attempt’ or ‘do not attempt’), (2) medical interven-
tion (‘treatment’ or ‘comfort measures’), (3) preferred 
place of medical treatment (‘home’ or ‘others’) and (4) 
preferred place of death (‘home’ or ‘others’). Multi-
variable logistic regression was performed to investigate 
the relationship between age and sex with these prefer-
ences. Adjusted odds ratios (ORs) were estimated from 
multivariable models and reported with corresponding 
95% confidence intervals (CIs). All statistical tests were 
conducted using Stata V.12,25 and a two-sided p value of 
0.05 was set as the level of statistical significance.
results
A total of 3380 completed ACP documents were captured 
in the databases, with approximately 90% completed in 
acute hospitals. The patient characteristics can be seen in 
table 1. Sixty per cent of the patients were aged 75 years 
and above, and there was demographic variation across 
the three types of ACP, with younger age profiles for those 
who completed the general and disease-specific forms. 
Among all individuals who completed the ACP, 53.2% 
(1798/3380) were deceased as of 31 December 2015, with 
the highest share for individuals with advanced illnesses. 
The overall median time between ACP completion and 
death was 7.27 months (95% CI 6.35 to 8.18); 63.2% 
completed ACP within 3 months prior to death, 52.9% 
within 6 months and 42.3% within 12 months.
Documented preferences
Data related to preferences for end-of-life care are 
represented in table 2. For healthy individuals who had 
completed the general ACP, one in eight persons indicated 
a preference for life-sustaining treatment. For individuals 
with chronic illnesses, close to one in three opted for CPR 
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and life-sustaining treatment, even if the likelihood of 
surviving the complications of the illness were low or if they 
were to lose their ability to move around or communicate. 
However, only 16.3% opted for full treatment if they were 
to become mentally incapacitated because of their illness.
For individuals with advanced illnesses (Table 2), 
5.7% opted for CPR and 5.1% opted for full medical 
intervention. The majority preferred the initiation of 
a limited trial of treatment, which would be continued 
with comfort measures if there was no clinical improve-
ment. Approximately 43.6% of individuals preferred to 
receive treatment in their homes, but 77.4% of these 
individuals would consider being transferred to an acute 
hospital after a trial of care at home. Only 29.7% stated 
the hospital as their preferred site of care. For place of 
death, 40.4% preferred dying at home, and only 14.1% 
preferred the hospital. One highlight is that although 
only 4.1% did not state any preference or were unsure 
about the place of care, 23% of respondents did not 
indicate their preferences with regards to the preferred 
place of death.
relationship between patient and sDM
The share of individuals who had appointed a substitute 
decision-maker varied across the three health states. The 
rates of nomination were, however, lower for those who 
were healthy or diagnosed with chronic illnesses. For those 
with advanced illnesses, only 6% of individuals did not 
identify a substitute decision-maker (table 2table 3). From 
table 4, 78% of individuals nominated their immediate 
family (spouse, children, grandchildren) to speak on their 
behalf if they were incapacitated. Only a small percentage 
nominated non-related persons. Most ACP discussions also 
took place in the acute care setting.
relationship between preferred place of care and place of 
death
Table 4 assessed the relationship between place of care 
and place of death. The results indicated that there 
was a high level of agreement and strong correlation 
in preferences related to being cared for at home and 
dying at home. Other than this, the place of care is not 
synonymous with where they would like to die at. Close 
to one in three individuals who preferred the hospital as 
the location of care had also opted for home as the place 
of death.
relationship between treatment preferences and patient 
profile
As age and sex were not correlated with preferences for 
healthy and chronically ill individuals, the results were 
excluded. Table 5 illustrates the results from a logistic 
regression to assess the impact of age and sex on the 
preferences of those with advanced illnesses. Those aged 
75 years and above were more likely to not opt for CPR 
and comfort measures, compared with younger individ-
uals. Care at home or having a trial of care at home was 
the preferred option for the older age group. Similarly, 
older people exhibited a stronger likelihood of prefer-
ring to die at home. There were no significant gender 
differences in preferences for CPR. However, there was 
a higher likelihood of women opting for full treatment 
than comfort measures. This is also consistent with the 
relatively lower odds of choosing home as the site of care 
and place of death, compared with men.
DIsCussIOn
This is the first study to have quantified actual prefer-
ences about end-of-life care, in a relatively large clin-
ical sample in Singapore. Other published studies have 
adopted a survey design to elicit preferences as part of 
research.14 15 26 The findings offered insights into deci-
sions made under real-life situations, where the stated 
preferences were supposed to reflect goals of care of the 
individual. Singapore stands apart being an Asian country 
that is strongly influenced by Western culture where the 
people have a strong desire for independence together 
with a collectivist mentality.27 The results of this study 
Table 1 Profile of individuals by health status
Variable Category
Health status
Total (n, %) P value
Healthy
(n, %)
Chronic illness
(n, %)
Advanced illness 
(n, %)
Age <55 years 77 (11.9) 6 (12.2) 142 (5.3) 225 (6.7) <0.001
55–64 years 193 (29.9) 14 (28.6) 259 (9.6) 466 (13.8)
65–74 years 203 (31.4) 17 (34.7) 445 (16.6) 665 (19.7)
≥75 years 173 (26.8) 12 (25.5) 1839 (68.5) 2024 (59.9)
Sex Female 359 (55.6) 19 (38.8) 1316 (49.0) 1694 (50.1) 0.001
Male 265 (41.0) 28 (57.1) 1335 (49.7) 1628 (48.2)
Missing 22 (3.4) 2 (4.1) 34 (1.3) 58 (1.7)
Deceased Yes 57 (8.8) 10 (20.4) 1731 (64.5) 1798 (53.2) <0.001
No 589 (91.2) 39 (79.6) 954 (35.5) 1582 (46.8)
Total 646 100.0) 49 (100.0) 2685 (100.0) 3380 (100.0)
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could therefore be of relevance to other Asian coun-
tries that are also experiencing rapid socioeconomic and 
demographic transitions.
In our study, most individuals nominated their family 
members to speak on their behalf if they were incapac-
itated, which is similar to what was observed in other 
studies.28 Among healthy and chronically ill patients, 
the majority did not opt for CPR or other life-sustaining 
measures. Among those with advanced illness, more than 
90% preferred not to attempt CPR, but more than 70% 
still preferred to receive some form of active medical 
treatment at the end-of-life, rather than comfort care. In 
this national sample, approximately 4 in 10 chose to be 
cared for and to die at home. Other Singaporean studies 
examined the preferences of nursing home residents29 
and those who received care in a day care centre.16 These 
studies similarly found that while most individuals did 
not opt for CPR, they did express a preference to receive 
some form of active treatment.16 29
In 2014, the Lien Foundation, a Singapore philanthropic 
house, commissioned a community-based survey to deter-
mine the death attitudes and the level of awareness about 
hospice and palliative care. The survey reported that 70% 
and 77% of the surveyed individuals would prefer to be 
cared for and to die at home, respectively.17 Preferences 
for medical treatment at home and for home deaths were 
significantly lower in our sample. Public opinions often do 
not coincide with the views of individuals who are close to 
the end of life.20 Other research, such as those examining 
health state valuation, have pointed out the differences 
between these two groups,30 reflecting different priorities 
and changing experiences. The complexity of choices 
Table 2 End-of-life care preferences in general and 
disease-specific ACP forms
Documented preferences n, %
Healthy individuals (n=646)
  Appointment substitute decision maker 581 (89.9)
  Comfort measures 560 (86.7)
  Life-sustaining treatments 79 (12.2)
Individuals with chronic illness (n=49)
  Appointment first substitute decision 
maker
35 (71.4)
  Appointment second substitute decision 
maker
15 (30.6)
  Serious complication with low chance of 
survival
   Full treatment 16 (32.7)
   Stop treatment 31 (63.3)
  Serious complication with loss of ability 
to move around or communicate
   Full treatment 15 (30.6)
   Stop treatment 32 (65.3)
  Serious complication with mental 
incapacity
   Full treatment 8 (16.3)
   Stop treatment 38 (77.6)
  Cardiopulmonary resuscitation
   Attempt 14 (28.6)
   Do not attempt 19 (38.8)
   Do not attempt if doctor believes low 
survival chances
14 (28.6)
Individuals with advanced illness (n=2685)
  Appointment first substitute decision 
maker
2526 (94.1)
  Appointment second substitute decision 
maker
1357 (50.5)
  Cardiopulmonary resuscitation
   Attempt 152 (5.7)
   Do not attempt 2511 (93.5)
   Do not attempt if doctor believes low 
survival chances
22 (0.8)
  Medical intervention
   Full treatment 138 (5.1)
   Limited additional interventions 1851 (68.9)
   Comfort measures only 677 (25.2)
   Unsure 19 (0.7)
  Preferred place of medical treatment
   Home 265 (9.8)
   Hospital 798 (29.7)
   Nursing home 166 (6.2)
   Hospice 131 (4.9)
Continued
Documented preferences n, %
  Trial of treatment before consider 
transfer to hospital
   Home 908 (33.8)
   Nursing home 269 (10.0)
   Hospice 28 (1.0)
   Others (no preference, unsure) 110 (4.1)
   Missing 10 (0.4)
  Preferred place of death
   Patient’s home 1084 (40.4)
   Hospital 379 (14.1)
   Nursing home 160 (5.9)
   Hospice 156 (5.8)
   Home or hospital/nursing home/
hospice
112 (4.2)
   Healthcare institution (hospital or 
nursing home or hospice)
177 (6.7)
   Others (no preference, unsure) 617 (23.0)
ACP, Advance Care Planning; CPR, cardiopulmonary resuscitation.
Table 2 Continued 
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also grows as death draws near.31 When healthy partici-
pants are asked to make decisions regarding hypothet-
ical scenarios about death and dying, the 'shock' or fear 
that he or she experiences32 about potentially dying in 
an unfamiliar environment could sway decisions towards 
the familiar, meaning the home. Juxtaposed against other 
priorities, such as pain and symptom management, and 
alleviating caregiver burden, the ‘cost’ of maintaining 
one’s decision to die at home may also increase.33 At the 
same time, the fear of the unfamiliar could decrease over 
time, as patients increasingly adapt to new living and care 
arrangements in other settings, such as nursing homes 
or hospices.34 One in five individuals have been found to 
change their preferences over time.18
We also found that, although the preferred place of 
care and place of death are related, they are not equiva-
lent. While only a small percentage of individuals did not 
have strict preferences about where they are being cared 
for, almost one in four individuals expressed that they had 
no preferred place of death. Other studies have similarly 
indicated that these two dimensions are not equivalent, 
although healthcare professionals may use them inter-
changeably in practice.35
In our study, the time between ACP completion and 
death was 7.3 months. While there is no objective optimal 
timing,36 this is relatively shorter than the median times 
(14–37 months) reported in the literature.37 38 Given that 
the discussion about preferences should occur before 
physical or mental incapacitation, earlier initiation can be 
beneficial to the patients. At the same time, it is important 
to strike a balance because conducting the ACP conver-
sation too early when preferences are still unstable39 
could lead to unrealistic choices based on hypothesised 
scenarios.37 ACP initiation should take into account 
patient and family receptivity and, ideally, precede major 
health deterioration that could lead to decisional inca-
pacitation.40 Different diseases have different pathways of 
functional declines,41 which also needs to be considered.
In our sample of patients with advanced illnesses, we 
found that age was positively associated with preferences 
to withhold life-sustaining treatments, which was similar 
to the findings of several studies.42 43 We found that 
Table 3 Relationship with substitute decision maker
Type of substitute
 Health status 
Total P value
Healthy
(n, %)
Chronic illness
(n, %)
Advanced 
illness (n, %)
Spouse 185 (28.6) 8 (16.3) 320 (11.9) 513 (15.2) <0.001
Child, child-in-law or grandchild 230 (35.6) 20 (40.8) 1869 (69.6) 2119 (62.7)
Other relatives and friends 136 (21.1) 2 (4.1) 266 (9.9) 404 (12.0)
Others (including healthcare 
professionals)
14 (2.2) 1 (2.0) 10 (0.4) 25 (0.7)
Missing 81 (12.5) 18 (36.7) 220 (8.2) 319 (9.4)
Total 646 (100.0) 49 (100.0) 2685 (100.0) 3380 (100.0)
Table 4 Preferred place of care and preferred place of death
Place of death
Place of care
 Home Hospital Hospice
Nursing 
home
Home to 
hospital/
hospice
Hospice 
to NH/
hospital Others# Total
  Home 90.9** 31.1 9.9 5.4 57.3 12.1 12.7 40.4
  Hospital 0.8 30.3** 0.0 1.2 9.7 13.7 2.7 14.1
  Hospice 0.8 3.1 67.9NS 0.6 2.6 3.3 4.5 5.8
  Nursing home 0.4 0.4 0.0 70.5NS 0.2 12.1* 0.0 6.0
  Home or 
hospital/nursing 
home/hospice
1.9 3.5 1.5 0.0 8.0** 2.0 2.7 4.4
  Healthcare 
institution
0.4 4.4 4.6 6.6* 1.2 30.3* 19.1 6.6
  Others# 4.9 26.7 16.0 15.7 20.9 26.7 58.2** 22.7
**p<0.01; *p<0.05.
# no preferences orunsure.
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individuals older than 75 years were more likely to opt 
for the home as the place of care and death; but other 
studies reported that younger individuals more strongly 
prefer home as the place of care,44 or that age did not 
have a significant effect.45 Cultural differences, in the 
meaning assigned to the ‘home’ as a place of care and 
death, or even the availability of alternative palliative care 
facilities in different countries, could have resulted in the 
mixed evidence. For instance, due to the availability of 
inpatient palliative care units in Japan, older individuals 
had stronger preferences for the patient palliative care 
unit as the site of care than home.44 Our finding, that 
women were less likely to prefer to be cared for and die 
at home, was similarly reported in other studies.46 47 This 
could reflect the general longer life expectancy of women 
compared with men. This reduced likelihood of spousal 
support at the end of life could make home less preferred 
as an option.48
Policy and practice implications
Currently, efforts to implement ACP are focused on the 
elderly and those with advanced illnesses. Based on the 
numbers of completed disease-specific forms, the take-up 
by chronically ill individuals is very low. While better inte-
gration of ACP with chronic disease management efforts 
or more rapid expansion of ACP to the outpatient and 
community settings could assist in improving coverage, 
additional resources would concurrently be needed to 
assist hospitals to expand coverage to younger adults, and 
bringing ACP conversations forward in the life cycle of an 
individual. Building community awareness of and accep-
tance towards ACP will be crucial.
Policies should also consider a range of perspectives and 
preferences, especially of subpopulations that they will 
most immediately affect. Preferences elicited from surveys 
can be viewed as an aspirational target that is achievable if 
practical barriers were eradicated. Additionally, due to the 
relatively high proportion of individuals who still preferred 
hospital as the location of care, policy-makers still need 
to focus on improving the end-of-life care experience in 
formal healthcare institutions, while also expanding home 
palliative care capacity to cater to those who preferred 
home as the first place of care and place of death.
limitations
The sample comprised largely the patients receiving care 
in the acute care hospitals. As such, the results may not be 
generalisable for patients in the community care settings 
or to other individuals who have elected not to partici-
pate in ACP. Individuals who had completed the ACP 
documentation could be less death avoidant and, there-
fore, have different preferences compared with others. 
We were only able to examine the relationship between 
preferences and patient age and sex due to limited avail-
ability of data. Other studies49 have also highlighted the 
importance of the family and care context on care prefer-
ences. A recent systematic review50 highlighted the lack of 
research evidence on ethnicity and religion, which is also 
absent from this study. Future research should explore 
the influence of these pertinent elements including a 
closer examination of the influence of different illnesses 
(advanced malignancy, end-stage organ failure or neuro-
degenerative diseases) on end-of-life care preferences.
COnClusIOn
This study identified that most of the individuals in our 
sample, regardless of health status, preferred not to 
proceed with life-sustaining treatments across a spectrum 
of health scenarios. However, individuals with advanced 
illnesses still preferred to receive some form of active 
support, for example, non-invasive ventilation support 
or oral and intravenous drug administration. Our results 
imply that policies should consider home-based end-of-
life care, and also actively focus on the quality of end-of-
life care in hospitals, since many individuals still opt for 
them as the site of care.
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Model includes variables: age and sex.
CPR, cardiopulmonary resuscitation; PPC, preferred plan of care.
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